The first project will focus on developing an AI-based platform for the sterically guided design of bispecific antibodies
These medicines are essential in preventing RhD immunisation during pregnancy
The company showcased three core programs developed through this platform
Vevzuo is authorized for the prevention of skeletal related events in adults with advanced malignancies involving bone
The approval in China is supported by a robust local clinical development program confirming the drug’s safety, tolerability, and efficacy profile
Eylea 8 mg is the first and only anti-vascular endothelial growth factor (VEGF) treatment in the EU with treatment intervals of up to 6 months for both patients with nAMD and DME
The company's decision to withdraw the MAA was due to the timing of the availability of Chemistry Manufacturing and Controls
WINREVAIR significantly reduced the risk of clinical worsening events in recently diagnosed PAH patients over 70 percent of whom were on double background therapy
The program will start with providing bTrastuzumab to cancer patients facing treatment delays due to budget constraints
Subscribe To Our Newsletter & Stay Updated
